Corinne Mercier

Title: Corinne Mercier: Innovator in Toxoplasmosis Diagnosis

Introduction

Corinne Mercier is a notable inventor based in La Tronche, France. She has made significant contributions to the field of medical diagnostics, particularly in the early detection of toxoplasmosis. Her innovative approach has the potential to improve patient outcomes through timely diagnosis.

Latest Patents

Corinne Mercier holds a patent for "Recombinant GRA antigens and the use of same for early diagnosis of toxoplasmosis." This patent describes a method for identifying the presence or absence of anti-antibodies in human or animal serum. The process involves placing previously drawn serum in contact with antigens capable of binding with the anti-antibodies. The observation of a bond or absence of a bond of antibodies with the antigens is crucial for diagnosis. The method utilizes a combination of two recombinant proteins, GRA2 and GRA6, which are attached to a support, such as an ELISA plate. This test is intended to supplement other diagnostic tests for toxoplasmosis.

Career Highlights

Throughout her career, Corinne has worked with esteemed institutions, including Université Joseph Fourier-Grenoble 1 and Centre Hospitalier Universitaire Grenoble. Her work in these organizations has allowed her to collaborate with other professionals in the field and contribute to advancements in medical research.

Collaborations

Corinne has collaborated with notable colleagues, including Marie-France Delauw and Hervé Pelloux. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.

Conclusion

Corinne Mercier's contributions to the field of toxoplasmosis diagnosis exemplify the importance of innovation in medical science. Her patented methods and collaborative efforts highlight her commitment to improving healthcare through advanced diagnostic techniques.